Clinical Trials Browser

Completed × Drug-Related Side Effects and Adverse Reactions × Sarcoma × Clear all

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04260113 2021-01-05

AIAC

Phase NA Completed

40 enrolled

Sarcoma

Chondrosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Phase 1 Completed

10 enrolled

CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT00004132 2013-06-26

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Phase 2 Completed

LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Radiation Injuries, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Drug-Related Side Effects and Adverse Reactions

Clinical Trials

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

AIAC

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer